India Price Regulator Wants At Least Five Drug Makers Charged
This article was originally published in PharmAsia News
Executive Summary
India's regulator of drug prices has called for legal action against five pharmaceutical companies on charges they violated price controls. The National Pharmaceutical Pricing Authority said the companies collectively sold 39 specified pack sizes of different drugs without prior approval of the prices. The firms named were Alembic, Cadilla Healthcare, Medley Pharmaceuticals, Lupin and Wockhardt. The NPPA said it also is looking at nearly 30 other cases of alleged overcharges and is asking the firms involved to repay the excess amounts. It asked state governments to begin prosecution proceedings. (Click here for more